Pierre Broqua

Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures

Pierre Broqua, Joseph G. Wettstein, M.N. Rocher et al. · Behavioural Pharmacology · 1995 · 199 citations

Medicine, Behavioral Sciences, Pharmacology +13

Chronic Inhibition of Circulating Dipeptidyl Peptidase IV by FE 999011 Delays the Occurrence of Diabetes in Male Zucker Diabetic Fatty Rats

Béatrice Sudre, Pierre Broqua, Richard White et al. · Diabetes · 2002 · 168 citations · Full text

Medicine, Endocrinology, Pharmacology +16

Pharmacological Profile of a New, Potent, and Long-Acting Gonadotropin-Releasing Hormone Antagonist: Degarelix

Pierre Broqua, Pierre Rivière, P. Michael Conn et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 151 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism

Paula Raposinho, D. D. Pierroz, Pierre Broqua et al. · Molecular and Cellular Endocrinology · 2001 · 143 citations

Medicine, Endocrinology, Physiology +17

GnRH Antagonists:  A New Generation of Long Acting Analogues Incorporating<i>p</i>-Ureido-phenylalanines at Positions 5 and 6

Guangcheng Jiang, Jacek Stalewski, Robert Galyean et al. · Journal of Medicinal Chemistry · 2000 · 110 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17